Uroflowmetry and Nocturnal Enuresis

Furkan Adem Canbaz

Status: Active, not recruiting

Conditions: Enuresis, Nocturnal

Treatments: Drug: Desmopressin lyophilisate (Melt); Drug: desmopressin melt form 120 μg; Drug: Propiverine tablet

Study type: Observational

Funder types: Other

Identifiers

NCT07028645

Ivstrh - UF PMNE

Details and patient eligibility

About

This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.

Full description

A total of approximately 100 patients with enuresis will be evaluated retrospectively. Uroflowmetry parameters of these patients will be evaluated. For this purpose, patients will be divided to mainly three groups according to the treatment choices.

Enrollment: 100 estimated patients

Sex: All

Ages: 5 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Presence of enuresis nocturna
• Patients who have uroflowmetry test

Exclusion criteria

• Presence of lower urinary tract symptoms
• Presence of anatomical or neurological problems
• Patients with missing data

Trial design

100 participants in 3 patient groups

Desmopressin 120mcg

Description:

Patients treated with desmopressin 120 mcg

Treatment:

Drug: desmopressin melt form 120 μg

Desmopressin 240 mcg

Description:

Patients treated with desmopressin 240mcg

Treatment:

Drug: Desmopressin lyophilisate (Melt)

Desmopressin 240 mcg + anticholinergic

Description:

Patients treated with desmopressin 240mcg + anticholinergic agent

Treatment:

Drug: Propiverine tablet